Showing 121 - 140 results of 75,774 for search '(( significant ((point decrease) OR (a decrease)) ) OR ( significant differences became ))', query time: 1.83s Refine Results
  1. 121
  2. 122
  3. 123
  4. 124
  5. 125

    Human cochlin bound to <i>N</i>-sulfated heparin and mutations in DFNA9 patients decreased binding affinity. by Tomoko Honda (5732531)

    Published 2022
    “…(B) <i>N</i>-desulfated, <i>N</i>-acetylated heparin significantly decreased binding affinity for cochlin. …”
  6. 126

    The number of gauging cross-sections where a statistically significant decreasing trend was identified. by Krzysztof Kochanek (835532)

    Published 2024
    “…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.…”
  7. 127
  8. 128
  9. 129
  10. 130
  11. 131
  12. 132

    FUD transiently decreased IOP in mice injected with Ad5-TGFβ2 viral vector. by Jennifer A. Faralli (4907311)

    Published 2020
    “…On Day 15, some TGFβ2 transduced mice received intracameral injections of FUD, PBS or mFUD. FUD significantly decreased IOP on Day 17 (2 days after FUD injection) (*p<0.05). …”
  13. 133
  14. 134
  15. 135

    Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

    Published 2022
    “…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…”
  16. 136
  17. 137
  18. 138
  19. 139

    The combination of LPS and PFC caused faster clot initiation and decreased clot strength. by Heather F. Pidcoke (9023789)

    Published 2022
    “…Comparing groups, there is a significant decline in TEG MA in LPS-PFC3 group compared to LPS-SAL group at T72 and T96 time points (p<0.05). …”
  20. 140

    Predictive value of RVT1 for the decreased RV ejection fraction (RVEF) and poor outcome in pulmonary arterial hypertension (PAH). by Ryotaro Asano (11767131)

    Published 2021
    “…(c) The receiver characteristics curve analysis for a decreased RVEF at follow-up. We defined a change of +3% or −3% (between baseline and follow-up over 12 months) as an increased or decreased RVEF, respectively. …”